The company forecast current-quarter revenue between $15.20 billion and $15.75 billion, compared with analysts’ average estimate of $16.07 billion, according to data from Refinitiv.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.